secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2024-03-01T23:59:59+00:00
Accession:  0001683168-24-001253
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma receives Nasdaq delisting notice; stock at $0.10 or less for 10 days
--------------------------------------------------------------------------------

- Nasdaq staff determined common stock bid price <= $0.10 for ten consecutive days as of Feb 27, 2024.
- Company appealed on Feb 28, 2024; hearing scheduled for April 25, 2024 stays delisting.
- Plans 40-for-1 reverse stock split after mailing definitive info statement to regain bid price compliance.
- If appeal not filed by March 6, trading would be suspended March 8 and a Form 25-NSE filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316824001253/0001683168-24-001253-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316824001253/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-001253

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer